Zevin Asset Management LLC Gilead Sciences, Inc. Transaction History
Zevin Asset Management LLC
- $631 Million
- Q1 2025
A detailed history of Zevin Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zevin Asset Management LLC holds 5,305 shares of GILD stock, worth $599,624. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,305
Previous 6,022
11.91%
Holding current value
$599,624
Previous $556,000
6.83%
% of portfolio
0.09%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,296Shares Held
999MCall Options Held
9.6MPut Options Held
10.1M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.3 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.73 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.17 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.05 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...